Patient Resources

This section includes information you can use to help your patients during treatment on Effient^® (prasugrel). If you have additional questions about Effient, you can call 1-866-Effient (1-866-333-4368). This toll-free number will connect you with a healthcare professional who can provide additional information. This is an informational service provided by Daiichi Sankyo, Inc. and Eli Lilly and Company.

You can also write to us at the following address:
Daiichi Sankyo, Inc. and Lilly USA, LLC
P.O. Box 6245
Indianapolis, IN 46206-6245

Patient Support

In patients who are managed with PCI and stent placement, premature discontinuation of any antiplatelet medication may result in an increased risk of stent thrombosis, MI, and death.¹ Patients with MI in the PREMIER registry who underwent PCI and stopped thienopyridine therapy by 30 days were almost 11 times more likely to die during the next 11 months (7.5% vs 0.7%).*²

*In the PREMIER registry, thienopyridine was clopidogrel or ticlopidine. Prasugrel was not available at the time of the study.

The Esstential Habits Program

Esstential Habits is a free program created by the makers of Effient to help your patients stay on track during recovery. The Esstential Habits program is designed to complement the support and information you provide.

Visit the patient site for Effient to watch a video tour of what the program has to offer your patients.

SELECTED SAFETY: DISCONTINUATION OF EFFIENT

Patients who experience stroke or TIA on Effient generally should discontinue therapy. Effient should also be discontinued for active bleeding and elective surgery. If possible, manage bleeding without discontinuing Effient. Premature discontinuation, particularly in the first few weeks after ACS, increases risk of stent thrombosis, MI, and death. Click here for Safety Information and Boxed Warning.